Barriers and proposed solutions to at‐home colorectal cancer screening tests in medically underserved health centers across three US regions to inform a randomized trial

Autor: Suzanne Brodney, Roopa S. Bhat, Jessica J. Tuan, Gina Johnson, Folasade P May, Beth A. Glenn, Kimberly Schoolcraft, Erica T. Warner, Jennifer S. Haas

Publikováno v: Cancer Medicine, Vol 13, Iss 15, Pp n/a-n/a (2024)

Abstract Introduction At‐home colorectal cancer (CRC) screening is an effective way to reduce CRC mortality, but screening rates in medically underserved groups are low. To plan the implementation of a pragmatic randomized trial comparing two popul

Externí odkaz: https://doaj.org/article/1cd4e80d3dd445f8ab21d245227790a6

Outcomes of pregnant women exposed to Sotrovimab for the treatment of COVID-19 in the BA.1 Omicron predominant era (PRESTO)

Autor: Jessica J. Tuan, Manas Sharma, Jehanzeb Kayani, Matthew W. Davis, Dayna McManus, Jeffrey E. Topal, Onyema Ogbuagu

Publikováno v: BMC Infectious Diseases, Vol 23, Iss 1, Pp 1-5 (2023)

Abstract Background Sotrovimab, a monoclonal antibody with efficacy against SARS-CoV-2 including certain Omicron variants, has been used in treatment of mild-moderate COVID-19. Limited data exists regarding its use in pregnant women. Methods Electron

Externí odkaz: https://doaj.org/article/9a39306f4b36452aa9fe53cf68299b0f

Long-term quantitative assessment of anti-SARS-CoV-2 spike protein immunogenicity (QUASI) after COVID-19 vaccination in older people living with HIV (PWH)

Autor: Jessica J. Tuan, Heidi Zapata, Lydia Barakat, Laurie Andrews, Anousheh Behnegar, Yee Won Kim, Jehanzeb Kayani, Suzana Mutic, Linda Ryall, Barbara Turcotte, Terese Critch-Gilfillan, Min Zhao, Syim Salahuddin, Shaili Gupta, Richard Sutton, Gerald Friedland, Brinda Emu, Onyema Ogbuagu

Publikováno v: BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-8 (2022)

Abstract Background The durability of immune responses to COVID-19 vaccines among older people living with HIV (PWH) is clinically important. Methods We aimed to assess vaccine-induced humoral immunity and durability in older PWH (≥ 55 years, n = 2

Externí odkaz: https://doaj.org/article/4d76945fe8924d5ca17b391abd87160f

Analysis of drug-drug interactions in patients with HIV and metabolic syndrome.

Autor: Tuan J; Yale School of Medicine, Department of Internal Medicine, Section of Infectious Diseases, New Haven, CT, USA.; Yale Antivirals and Vaccines Research Program, New Haven, CT, USA., Igiraneza G; Yale Antivirals and Vaccines Research Program, New Haven, CT, USA., Ogbuagu O; Yale School of Medicine, Department of Internal Medicine, Section of Infectious Diseases, New Haven, CT, USA.; Yale Antivirals and Vaccines Research Program, New Haven, CT, USA.

Publikováno v: Expert opinion on drug metabolism & toxicology [Expert Opin Drug Metab Toxicol] 2024 Oct; Vol. 20 (10), pp. 953-965. Date of Electronic Publication: 2024 Sep 10.

COVID-19 Vaccine Efficacy in Participants With Weakened Immune Systems From 4 Randomized Controlled Trials.

Autor: Sherman AC; Department of Medicine, Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Tuan J; Yale School of Medicine, Section of Infectious Diseases, New Haven, Connecticut, USA., Cantos VD; Division of Infectious Diseases, Emory University, Atlanta, Georgia, USA., Adeyiga O; Department of Medicine, Division of Infectious Diseases, University of California, Los Angeles, Los Angeles, California, USA., Mahoney S; Department of Medicine, University of Cape Town, Desmond Tutu HIV Centre, Cape Town, South Africa., Ortega-Villa AM; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Tillman A; Frederick National Laboratory for Cancer Research, Clinical Monitoring Research Program Directorate, Frederick, Maryland, USA., Whitaker J; Department of Molecular Virology and Microbiology and Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA., Woodward Davis AS; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Leav B; Moderna Inc., Cambridge, Massachusetts, USA., Hirsch I; Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Sadoff J; Janssen Vaccines and Prevention, Leiden, Netherlands., Dunkle LM; Novavax, Gaithersburg, Maryland, USA., Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Janes HE; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Goepfert PA; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA., Kotloff K; Department of Pediatrics and the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA., Rouphael N; Hope Clinic, Emory University, Atlanta, Georgia, USA., Falsey AR; Infectious Disease Division, University of Rochester, Rochester, New York, USA., El Sahly HM; Department of Molecular Virology and Microbiology and Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA., Sobieszczyk ME; Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA., Huang Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Neuzil KM; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA., Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA., Grinsztejn B; National Institute of Infectious Diseases-Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Gray G; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; South African Medical Research Council, Cape Town, South Africa., Nason M; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Baden LR; Department of Medicine, Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Gay CL; Department of Medicine, Division of Infectious Diseases, UNC HIV Cure Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Aug 16; Vol. 79 (2), pp. 364-374.